Ansiedad y Depresión en Síndrome Coronario Agudo

Medicrit : Revista de Medicina Crítica 02/2009; DOI: 10.5413/mrmc.2009.61.112
Source: DOAJ

ABSTRACT Antecedentes. La falta de regulación autonómica cardiaca en los pacientes portadores de ansiedad y o depresión y cardiopatía isquémica; está relacionado con altos índices de morbilidad y mortalidad cardiaca. Objetivo. Determinar la prevalencia de depresión en sujetos con SICA. Método. Diseño: Transversal. Se realizó una encuesta a 139 sujetos con SICA. Se aplicaron inventarios: ansiedad y depresión en pacientes hospitalizados y cardiopatía isquémica/depresión (Hospitalizad Anxiety Depresion Scale [HADS]) y DMI-10, respectivamente, con alfa de Cronbach > 0.85.De acuerdo a los criterios de la American Psychiatric Association. DSM-IV TR. Resultados. La prevalencia de Depresión en SICA fue con DMI-10 de 42 (31.2%); IC 95%(23.4–38.9) y por el inventario de HADS de 12 (8.6%); IC (3.9–13.2) P < 0.005, y la ansiedad de 53 sujetos (38.12%); IC (30.1–46.1) P < 0.05.Además el inventario de DMI-10 y HADS tuvo una correlación con el estadístico tb de Kendall de 0.350 con valor de P < 0.005. Y grado de acuerdo por estadístico de Kappa ponderado para variables ordinales Kw=0.586 con valor de P=< 0.05. Conclusión. La depresión mayor parece ser similar a lo reportado en la literatura mundial. Palabras clave: Ansiedad; depresión mayor; cardiopatía isquémica.

1 Follower
38 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Depression and low perceived social support (LPSS) after myocardial infarction (MI) are associated with higher morbidity and mortality, but little is known about whether this excess risk can be reduced through treatment. To determine whether mortality and recurrent infarction are reduced by treatment of depression and LPSS with cognitive behavior therapy (CBT), supplemented with a selective serotonin reuptake inhibitor (SSRI) antidepressant when indicated, in patients enrolled within 28 days after MI.Design, Setting, and Randomized clinical trial conducted from October 1996 to April 2001 in 2481 MI patients (1084 women, 1397 men) enrolled from 8 clinical centers. Major or minor depression was diagnosed by modified Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria and severity by the 17-item Hamilton Rating Scale for Depression (HRSD); LPSS was determined by the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI). Random allocation was to usual medical care or CBT-based psychosocial intervention. Cognitive behavior therapy was initiated at a median of 17 days after the index MI for a median of 11 individual sessions throughout 6 months, plus group therapy when feasible, with SSRIs for patients scoring higher than 24 on the HRSD or having a less than 50% reduction in Beck Depression Inventory scores after 5 weeks. Composite primary end point of death or recurrent MI; secondary outcomes included change in HRSD (for depression) or ESSI scores (for LPSS) at 6 months. Improvement in psychosocial outcomes at 6 months favored treatment: mean (SD) change in HRSD score, -10.1 (7.8) in the depression and psychosocial intervention group vs -8.4 (7.7) in the depression and usual care group (P<.001); mean (SD) change in ESSI score, 5.1 (5.9) in the LPSS and psychosocial intervention group vs 3.4 (6.0) in the LPSS and usual care group (P<.001). After an average follow-up of 29 months, there was no significant difference in event-free survival between usual care (75.9%) and psychosocial intervention (75.8%). There were also no differences in survival between the psychosocial intervention and usual care arms in any of the 3 psychosocial risk groups (depression, LPSS, and depression and LPSS patients). The intervention did not increase event-free survival. The intervention improved depression and social isolation, although the relative improvement in the psychosocial intervention group compared with the usual care group was less than expected due to substantial improvement in usual care patients.
    JAMA The Journal of the American Medical Association 06/2003; 289(23):3106-16. DOI:10.1001/jama.289.23.3106 · 35.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The extent to which depression impairs health-related quality of life (HRQoL) in the physically ill has not been clearly established. To quantify the adverse influence of depression and anxiety, assessed at the time of first myocardial infarction and 6 months later, on the physical aspect of HRQoL 12 months after the infarction. In all, 260 in-patients, admitted following first myocardial infarction, completed the Hospital Anxiety and Depression Scale and the Medical Outcomes Study SF-36 assessment before discharge and at 6- and 12-month follow-up. Depression and anxiety 6 months after myocardial infarction predicted subsequent impairment in the physical aspects of HRQoL (attributable adjusted R(2)=9%, P<0.0005). These negative effects of depression and anxiety on outcome were mediated by feelings of fatigue. Depression and anxiety present before myocardial infarction did not predict HRQoL 12 months after myocardial infarction. Detection and treatment of depression and anxiety following myocardial infarction improve the patient's health-related quality of life.
    The British Journal of Psychiatry 10/2006; 189(4):367-72. DOI:10.1192/bjp.bp.105.018234 · 7.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Major depression affects about one in five patients in the weeks after an acute myocardial infarction and is associated with an increased risk of cardiac morbidity and mortality. Consequently, there is considerable interest in the question of whether treating depression will improve medical prognosis in these patients. Safe, effective treatments for depression are available, but unless they also improve the underlying pathophysiological or behavioral mechanisms that contribute to cardiac morbidity and mortality, they may not have beneficial effects on prognosis. Altered cardiac autonomic tone is one of the leading candidate mechanisms. Unfortunately, a review of the available research reveals that cardiac autonomic tone often fails to normalize in patients treated for depression, and the research suggests that currently available treatments for depression will not necessarily improve cardiac event-free survival in patients who have had an acute myocardial infarction. Until there is convincing evidence that treatment can reduce the risk of cardiac morbidity and mortality, the principal reason to treat depression should continue to be to improve the quality of life of the patient who has had an acute myocardial infarction. Key words: depression, coronary heart disease, mortality.
    Psychosomatic Medicine 09/1999; 61(5):666-75. DOI:10.1097/00006842-199909000-00009 · 3.47 Impact Factor
Show more


38 Reads
Available from